Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
News and Events

Featured Stories

Hot information:
Top 10 Global CDMO Enterprises| Top 10 Global Clinical Research Organizations in 2021| The Meaning of IND, NDA and ANDA
Jul 24,2015
Flu Vaccine Becomes Universal
While many of us are spending the last half of the summer deciding where the nicest beaches are and who makes the best island cocktails, infectious disease scientists are looking ahead toward the next inevitable outbreak of the flu.  Influenza hunters travel to hot zones that have long been the traditional breeding grounds and launchingRead more
More
Jul 24,2015
New Molecular Inhibitor Stimulates Tissue Regeneration
The ability to create agents that promote tissue regeneration would have overwhelmingly beneficial implications within the clinical setting. Now, a collaboration of researchers from UT Southwestern Medical Center, Case Western Reserve University, and the University of Kentucky has identified an enzyme they say regulates tissue regeneration. The scientists believe that the inhibition of this enzymeRead more
More
New Molecular Inhibitor Stimulates Tissue Regeneration
Jul 23,2015
New Hope for ALS Sufferers
Researchers at the CHUM Research Center and the University of Montreal report the discovery of a previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The scientists believe their research paves the way to an entirely new approach for findingRead more
More
New Hope for ALS Sufferers
Jul 23,2015
An Aspirin a Day Keeps the Breast Cancer Away
The list of things that aspirin can do gets seemingly larger every year. Beyond its initial indication for the treatment of headaches and migraines, low-dose aspirin has been indicated, arguably, for patients to prevent cardiac episodes or the reoccurrence of cardiac issues in individuals who previously had a heart attack or mild stroke. Furthermore, previousRead more
More
An Aspirin a Day Keeps the Breast Cancer Away
Jul 22,2015
Detecting Disease with Intelligent Bacteria
We most often think of bacteria as tiny imperceptible organisms that often cause us to become irritatingly sick or as the origin of terrible disease epidemics. At best, some may view microbes as quasi-helpful when they are packaged in the form of probiotic food or supplement. What if, however, we were able to use bacterialRead more
More
Detecting Disease with Intelligent Bacteria
Jul 22,2015
Merck & Co. Extends $100M Agenus Cancer Collaboration
Agenus said today that Merck & Co. has extended their year-old, approximately $100 million-plus collaboration for the discovery and development of therapeutic antibodies against undisclosed Merck immune checkpoints for cancer. The collaboration's discovery phase has been extended to April 2016, Agenus said. "This collaboration has resulted in encouraging outcomes, and we're delighted that a leaderRead more
More
Jul 21,2015
Vaccine and Biotherapeutic Linked in New Effort to Combat Cancer
A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials. One therapy is a vaccine that targets a structure on the outside of cancer cells, while the other is an altered enzyme that breaks apart RNA and causes the cell toRead more
More
Jul 20,2015
New Tools Developed to Study Protein Formation
Scientists generated new antibodies that tag essential chemicals involved in protein formation. In this dividing cell, the new antibody marks discrete areas of a critical chemical reaction that occurs when cells divide. While we may be in the midst of the genomic era, being able to sequence genomes at speeds only rivaled by the molecularRead more
More
Jul 17,2015
Pfizer CTI, Foundation Launch Immunological Disease Collaboration
Pfizer's Centers for Therapeutic Innovation (CTI) and the Jeffrey Modell Foundation (JMF) have agreed to collaborate intended to advance research into immunological diseases. CTI and JMF will identify and co-fund translational research projects with leading academic medical centers within the CTI network. The goal of each research project will be to identify and validate aRead more
More
Pfizer CTI, Foundation Launch Immunological Disease Collaboration
Jul 16,2015
Global Biosimilars Market Value Could Hit $55 Billion
The global biosimilars market value is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, with growth primarily driven by a promising pipeline in active development and government efforts to reduce healthcare spending, according to business intelligence provider GBI Research.   The company's latest CBR Pharma report,Read more
More
Global Biosimilars Market Value Could Hit $55 Billion